|
|
|
Zyprexa - Class Action Information
|
Zyprexa, an antipsychotic drug also known as Olanzapine, normally prescribed for the treatment of schizophrenia and bipolar mania, has been linked
to serious side effects including diabetes, hyperglycemia, pancreatitis, ketoacidosis, and diabetic coma. To this point there have been 288 reported
diabetes cases in Zyprexa patients, with 23 of them being fatal.
The drug has been controversial since its introduction by Eli Lilly and especially after the Japanese Health and Welfare Ministry as well as the Great
Britain Medicines Control Agency issued emergency warnings due to numerous diabetes reports in 2002. A 2002 Duke University Zyprexa study also documented
cases of diabetes, which were supported by numerous other studies. A class action Zyprexa lawsuit has now been filed against Eli Lilly on
behalf of all Zyprexa users.
Eli Lilly is accused of promoting the drug Zyprexa as safe and effective for psychotic disorders while essentially concealing the known risks of
side effects from both doctors and patients. In a recent lawsuit, the courts agreed with consumers and found that prior to 2003, Eli
Lilly did not properly disclose the risks and known side effects of Zyprexa.
In September 2005 Eli Lilly and Co. finalized a settlement of $700 million in a lawsuit charging the pharmaceutical company of failing to disclose
health risks in Zyprexa labeling. $690 million in settlement funds will be dispersed to the 8,000 plaintiffs.
Return to Main
|
|
